Thus, these findings indicate that tumor-derived IL-6 and MDSC infiltration are both unfavorable prognostic factors in breast cancer and are significantly correlated with aggressive tumor behavior and poor clinical outcomes in patients. This evidence concerns the gene IL6 and breast cancer.